Acorda Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Acorda Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Acorda Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$27.4M, a 62.8% decline year-over-year.
  • Acorda Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was -$263M, a 352% decline year-over-year.
  • Acorda Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$253M, a 284% decline from 2022.
  • Acorda Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$65.9M, a 36.6% increase from 2021.
  • Acorda Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$104M, a 4.38% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$253M -$187M -284% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$65.9M +$38M +36.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$104M -$4.36M -4.38% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$99.6M +$173M +63.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-18
2019 -$273M -$307M -910% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 $33.7M +$257M Jan 1, 2018 Dec 31, 2018 10-K 2020-02-28
2017 -$223M -$189M -545% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$34.6M -$45.7M -413% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $11.1M -$6.61M -37.4% Jan 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
2014 $17.7M +$1.23M +7.49% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $16.4M -$139M -89.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $155M +$124M +406% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 $30.6M +$42.4M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-03
2010 -$11.8M Jan 1, 2010 Dec 31, 2010 10-K 2013-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.